Based on record review, and interview, the facility failed to ensure that one Resident (#3) of five applicable residents sampled for unnecessary medications, out of a total sample of 29 residents, was free from unnecessary psychotropic (medication that affect how the brain works and causes changes in mood, awareness, thoughts, feelings, perception and behaviors) medications.Specifically, for Resident #3, the facility failed to monitor for potential side effects and evaluate the Resident's response to Seroquel (Quetiapine - antipsychotic medication), Klonopin (Clonazepam - benzodiazepam medication), Ativan (Lorazepam - benzodiazepam medication), and Zoloft (Sertraline - antidepressant medication) medications, placing the Resident at risk for unidentified medication side effects and/or… …
F605 citations in Massachusetts
Freedom from Abuse, Neglect, and Exploitation Deficiencies
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Massachusetts cites F605 less often than its own record predicts
0.71 times the national share — cited less often here than elsewhere.
Of every deficiency written in Massachusetts in 2025, this is the portion that was F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Massachusetts surveyors wrote
F605 findings written in Massachusetts, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Massachusetts surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction